Tocilizumab in patients with moderate or severe COVID-19: a randomized, controlled, open-label, multicenter trial
托珠单抗治疗中重度 COVID-19 患者:一项随机、对照、开放标签、多中心试验
期刊:Frontiers of Medicine
影响因子:3.5
doi:10.1007/s11684-020-0824-3
Wang, Dongsheng; Fu, Binqing; Peng, Zhen; Yang, Dongliang; Han, Mingfeng; Li, Min; Yang, Yun; Yang, Tianjun; Sun, Liangye; Li, Wei; Shi, Wei; Yao, Xin; Ma, Yan; Xu, Fei; Wang, Xiaojing; Chen, Jun; Xia, Daqing; Sun, Yubei; Dong, Lin; Wang, Jumei; Zhu, Xiaoyu; Zhang, Min; Zhou, Yonggang; Pan, Aijun; Hu, Xiaowen; Mei, Xiaodong; Wei, Haiming; Xu, Xiaoling